Aminoglutethimide

In the US, Aminoglutethimide (aminoglutethimide systemic) is a member of the drug class adrenal corticosteroid inhibitors and is used to treat Breast Cancer, Cushing's Syndrome and Prostate Cancer.

US matches:

• Aminoglutethimide

Scheme

Rec.INN

CAS registry number (Chemical Abstracts Service)

0000125-84-8

Chemical Formula

C13-H16-N2-O2

Molecular Weight

232

Therapeutic Category

Antineoplastic agent

Chemical Name

2,6-Piperidinedione, 3-(4-aminophenyl)-3-ethyl-

Foreign Names

• Aminoglutethimidum (Latin)
• Aminoglutethimid (German)
• Aminoglutéthimide (French)
• Aminoglutetimida (Spanish)

Generic Names

• Aminoglutethimide (OS: BAN)
• Aminoglutéthimide (OS: DCF)
• Ba 16038 (IS)
• C 16038-BA (IS)
• Elipten (IS)
• Aminoglutethimid (PH: Ph. Eur. 6)
• Aminoglutethimide (PH: BP 2010, USP 32, Ph. Eur. 6)
• Aminoglutéthimide (PH: Ph. Eur. 6)
• Aminoglutethimidum (PH: Ph. Eur. 6)

Brand Names

• Aminoglutethimid Actavis
  Actavis, Bulgaria



• Aminoglutetimid
  Actavis, Georgia



• Cytadren
  Ciba Vision, United States; Novartis, Australia



• Mamomit
  Pliva, Bosnia & Herzegowina; Pliva, Georgia; Pliva, Croatia (Hrvatska); Pliva, Russian Federation



• Orimeten
  Novartis, Brazil; Novartis, Ghana; Novartis, Kenya; Novartis, Luxembourg; Novartis, Libya; Novartis, Nigeria; Novartis, Netherlands; Novartis, Sudan; Novartis, Tanzania; Novartis, Zimbabwe



• Orimetene
  Novartis, Hong Kong; Novartis, Taiwan



• Rogluten
  Sindan, Romania

International Drug Name Search

Glossary

BAN	British Approved Name
DCF	Dénomination Commune Française
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.